Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patients’ Views of Treatment‐Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing

11 May 2018

Abstract excerpt

This paper explores patients' views and experiences of undergoing treatment-focused BRCA1 and BRCA2 genetic testing (TFGT), either offered following triaging to clinical genetics (breast cancer) or as part of a mainstreamed care pathway in oncology (ovarian cancer). Drawing on 26 in-depth interviews with patients with breast or ovarian cancer who had undergone TFGT, this retrospective study examines patients'...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to CRISPR and Genetic Engineering
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29752676
DOI: 10.1007/s10897-018-0261-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Patients’ Views of Treatment‐Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 TestingPMID 29752676Read ↗

Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.Semantic proximity Read ↗

Universal BRCA1/BRCA2 Testing for Ovarian Cancer Patients is Welcomed, but with Care: How Women and Staff Contextualize Experiences of Expanded Access.Semantic proximity Read ↗

When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer.Semantic proximity Read ↗

Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative studySemantic proximity Read ↗

There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer.Semantic proximity Read ↗

Psychosocial experiences and outcomes for individuals with breast cancer after mainstream genetic testingSemantic proximity Read ↗

How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.Semantic proximity Read ↗

Breast cancer patients' experiences and outcomes of mainstream genetic testing with and without genetic counseling.Semantic proximity Read ↗

Perceptions and care Recommendations from Previvors: Qualitative analysis of female BRCA1/2 mutation Carriers’ experience with genetic testing and counselingSemantic proximity Read ↗

An Australian mainstream genetic testing program: Clinicians views about current and future practicesSemantic proximity Read ↗

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.Semantic proximity Read ↗

An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.